“Allowing a suit of this type to proceed on this basis would basically open the door to enabling any purchaser of any consumable product to file a lawsuit simply saying, ‘I bought product X, and it contains microplastics’ … and thereby get a past a motion to dismiss and into discovery and class certification proceedings,” wrote U.S. District Judge Matthew F. Kennelly.
‘Blanket HIPAA-Based Objection’ Doesn’t Shield Agency From Disclosing Gender-Affirming Care Info, Court Says
“Although HIPAA prohibits wrongful disclosure of [protected health information] PHI,